Related Experiment Video
Updated: Aug 5, 2026
11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
CD86 in Dendritic Cell-Mediated Cancer Immunity: From Maturation Marker to Functional Regulator
Ting-Wei Wu1, Chu-Hsin Chuang2, Yi-Hui Wu3,4,5
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chi Mei Hospital, Liouying, Tainan 73657, Taiwan.
Biomedicines
|July 28, 2026
Summary
CD86 regulation in dendritic cells is complex, influenced by immune checkpoints and the tumor microenvironment. Understanding this dynamic molecule is crucial for improving dendritic cell cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Signaling
Background:
- Dendritic cell (DC)-based cancer immunotherapy faces challenges due to varied immune responses and clinical outcomes.
- CD86, a co-stimulatory molecule, is traditionally seen as a DC maturation marker but is increasingly understood to be regulated by immune checkpoints and the tumor microenvironment (TME).
Purpose of the Study:
- To review the molecular mechanisms governing CD86 regulation in DCs.
- To discuss the influence of the TME on DC function and CD86 expression.
- To explore the heterogeneity of CD86 regulation and its implications for cancer immunity.
Main Methods:
- Literature review of molecular mechanisms regulating CD86.
- Analysis of immune checkpoint interactions (e.g., CTLA-4) and intracellular pathways (e.g., MARCH1-mediated ubiquitination).
- Examination of TME factors like cytokines, hypoxia, and metabolic stress on DC function.
Main Results:
- CD86 regulation is influenced by co-stimulatory signals, immune checkpoints, and TME-associated suppression.
- CD86 exhibits heterogeneity across DC subsets and immune contexts.
- Soluble CD86 (sCD86) is associated with immune activation and dysregulated immune states in cancer.
Conclusions:
- CD86 is a dynamic immunoregulatory molecule, not just a maturation marker, with context-dependent roles in cancer immunity.
- Further research is needed to clarify the mechanistic role, prognostic value, and therapeutic potential of CD86 in various cancer settings.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...